Neurosurgical and Neuroendovascular Management of Takayasu's Arteritis

医学 动脉炎 外科 血运重建 灌注 血管内治疗 大动脉炎 放射科 大动脉炎 锁骨下动脉 血管炎 心脏病学 内科学 动脉瘤 疾病 心肌梗塞
作者
Marcus A. Stoodley,Reid C. Thompson,R. Scott Mitchell,Michael P. Marks,Gary K. Steinberg
出处
期刊:Neurosurgery [Oxford University Press]
卷期号:46 (4): 841-852 被引量:5
标识
DOI:10.1097/00006123-200004000-00014
摘要

The roles of surgical and endovascular treatments for patients with Takayasu's arteritis are not clear. We report our experience in the neurosurgical and/or neuroendovascular treatment of patients with Takayasu's arteritis who exhibited ischemic neurological symptoms.Between 1994 and 1998, seven patients with Takayasu's arteritis and neurological symptoms were treated at the Stanford University Medical Center. All patients were angiographically evaluated and received maximal medical therapy. Cerebral blood flow studies were performed for six patients. Three patients underwent surgical revascularization procedures alone, two underwent combinations of surgical and endovascular procedures, and two underwent endovascular treatment alone.The most common neurological symptoms were dysequilibrium, syncope, and visual disturbances. The characteristic angiographic features of Takayasu's arteritis were identified for all patients. The subclavian arteries and proximal carotid and vertebral arteries were involved in all patients. Two patients exhibited improvement of their symptoms after endovascular treatment alone. There were two deaths after surgery, involving patients with severe global cerebral hypoperfusion. All other surgically treated patients exhibited improvement of their symptoms, with patent grafts, up to 4 years after surgery. Cerebral blood flow improved after treatment.Improvement of symptoms can be achieved with surgical revascularization and/or endovascular treatment. Staged revascularization might be better than one-stage bilateral high-flow grafting for patients with severe global hypoperfusion.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
需要交流的铅笔完成签到 ,获得积分10
刚刚
麦麦发布了新的文献求助10
刚刚
刚刚
刚刚
虔三愿发布了新的文献求助10
1秒前
1234完成签到,获得积分10
2秒前
qingyue发布了新的文献求助10
3秒前
3秒前
3秒前
潇洒书包发布了新的文献求助10
3秒前
4秒前
1234发布了新的文献求助10
5秒前
dream完成签到 ,获得积分10
6秒前
北方集群完成签到,获得积分10
6秒前
6秒前
Owen应助A拉拉拉采纳,获得10
7秒前
火猫三丈发布了新的文献求助10
7秒前
9秒前
muxi暮夕发布了新的文献求助10
9秒前
发嗲的枕头完成签到,获得积分20
9秒前
哈哈贤发布了新的文献求助10
10秒前
11秒前
11秒前
12秒前
现代乌龟完成签到,获得积分10
13秒前
15秒前
清响完成签到,获得积分10
15秒前
15秒前
zilhua发布了新的文献求助10
15秒前
张志迪发布了新的文献求助10
15秒前
陈老师耶发布了新的文献求助10
16秒前
琦琦完成签到,获得积分10
17秒前
mhy发布了新的文献求助10
17秒前
18秒前
18秒前
19秒前
19秒前
19秒前
19秒前
彭于晏应助小猪顺利升博采纳,获得10
20秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
The Conscience of the Party: Hu Yaobang, China’s Communist Reformer 600
MATLAB在传热学例题中的应用 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3302828
求助须知:如何正确求助?哪些是违规求助? 2937174
关于积分的说明 8480818
捐赠科研通 2611083
什么是DOI,文献DOI怎么找? 1425572
科研通“疑难数据库(出版商)”最低求助积分说明 662379
邀请新用户注册赠送积分活动 646788